Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep 24;71(3):411-419.
doi: 10.33073/pjm-2022-036. eCollection 2022 Sep 1.

Opportunistic Candida Infections in Critical COVID-19 Patients

Mıne Altinkaya Çavuş  1 , Hafıze Sav  2
Affiliations

Opportunistic Candida Infections in Critical COVID-19 Patients

Mıne Altinkaya Çavuş et al. Pol J Microbiol. .

Abstract

The frequency of opportunistic fungal infections in critically ill patients whose intensive care unit stays are prolonged due to coronavirus disease 2019 (COVID-19) is higher than in the period before COVID-19. We planned this study to improve the management of Candida infections by defining the Candida species, the etiology of infections caused by Candida species, and the antifungal susceptibility of the species. This retrospective study included patients older than 18 hospitalized in the intensive care unit (ICU) with a definitive diagnosis of COVID-19 for seven months (from March 2021 to September 2021). All study data that we recorded in a standard study form were analyzed with TURCOSA (Turcosa Analytics Ltd. Co., Turkey, www.turcosa.com.tr) statistical software. The patients were evaluated in four groups as group 1 (candidemia patients, n = 78), group 2 (candiduria patients, n = 189), group 3 (control patients, n = 57), and group 4 (patients with candidemia in urine cultures taken before Candida was detected in blood culture, n = 42). Candida species were identified using both conventional and VITEK® 2 (BioMérieux, France) methods. The antifungal susceptibility of fungi was determined using the E test method. Of the 5,583 COVID-19 patients followed during the study period, 78 developed candidemia, and 189 developed candiduria. The incidence of candidemia (per 1,000 admissions) was determined to be 1.6. As a result of statistical analysis, we found that Candida albicans was the dominant strain in candidemia and candiduria, and there was no antifungal resistance except for naturally resistant strains. Candida strains grown in blood and urine were the same in 40 of 42 patients. Mortality was 69.2% for group 1, 60.4% for group 2, and 57.8% for group 3. Antifungals were used in 34 (43.5%) patients from group 1, and 95 (50.2%) from group 2. In the candidemia group without antifungal use, mortality was quite high (77.2%). Antifungal use reduced mortality in the group 2 (p < 0.05). Length of ICU stays, comorbidity, broad-spectrum antibiotics, and corticosteroids are independent risk factors for candidemia in critically ill COVID-19 patients. Our study contributes to the knowledge of risk factors for developing COVID-19-related candida infections. The effect of candiduria on the development of candidemia in critically ill COVID-19 patients should be supported by new studies.

Keywords: COVID-19; critical care; opportunistic Candida infections.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest

The authors do not report any financial or personal connections with other persons or organizations, which might negatively affect the contents of this publication and/ or claim authorship rights to this publication.

Figures

Fig. 1
Fig. 1
Antifungal (AF) use/mortality graph.
See this image and copyright information in PMC

References

    1. Arastehfar A, Carvalho A, Nguyen MH, Hedayati MT, Netea MG, Perlin DS, Hoenigl M. COVID-19-associated candidiasis (CAC): An underestimated complication in the absence of ımmunological predispositions? J Fungi (Basel) 2020;6(4):211. doi: 10.3390/jof6040211. Oct 8. - DOI - PMC - PubMed
    1. Arastehfar A, Carvalho A, van de Veerdonk FL, Jenks JD, Koehler P, Krause R, Cornely OA, S Perlin D, Lass-Flörl C, Hoenigl M. COVID- 19 associated pulmonary aspergillosis (CAPA) – from immunology to treatment. J Fungi (Basel) 2020a;6(2):91. doi: 10.3390/jof6020091. - DOI - PMC - PubMed
    1. Arastehfar A, Shaban T, Zarrinfar H, Roudbary M, Ghazanfari M, Hedayati MT, Sedaghat A, Ilkit M, Najafzadeh MJ, Perlin DS. Candidemia among Iranian patients with severe COVID-19 admitted to ICUs. J Fungi (Basel) 2021;7(4):280. doi: 10.3390/jof7040280. Apr 08. - DOI - PMC - PubMed
    1. Bastos GAN, Azambuja AZ, Polanczyk CA, Gräf DD, Zorzo IW, Maccari JG, Haygert LS, Nasi LA, Gazzana MB, Bessel M. Clinical characteristics and predictors of mechanical ventilation in patients with COVID- 19 hospitalized in Southern Brazil. Rev Bras Ter Intensiva. 2020;32(4):487–492. doi: 10.5935/0103-507X.20200082. et al. Oct-Dec. - DOI - PMC - PubMed
    1. Binelli CA, Moretti ML, Assis RS, Sauaia N, Menezes PR, Ribeiro E, Geiger DCP, Mikami Y, Miyaji M, Oliveira MS. Investigation of the possible association between nosocomial candiduria and candidaemia. Clin Microbiol Infect. 2006;12(6):538–543. doi: 10.1111/j.1469-0691.2006.01435.x. et al. Jun. - DOI - PubMed